activation of EGFR in head and neck SCC in vitro resulted in increased tumor sphere formation, while treatment with gefitinib, also in vitro, decreased the capacity of putative cancer stem cells to invade and made them more sensitive to cisplatin-induced death (abhold et al., 2012). The gene discussed is EGFR; the disease is cancer.